SARS-Cov-2 vaccination is safe in autoimmune pancreatitis patients

United European Gastroenterol J. 2024 Feb;12(1):159-161. doi: 10.1002/ueg2.12526. Epub 2024 Jan 5.

Authors

Lukas Perkhofer^{1

2}, Katja Kilani¹, Ägädius Wieser¹, Thomas Seufferlein³, Pauline Kleger⁴, Martin Mueller³, Alexander Kleger^{1

2}

Affiliations

¹ Section of Interdisciplinary Pancreatology, Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany.
² Institute of Molecular Oncology and Stem Cell Biology, Ulm University Hospital, Ulm, Germany.
³ Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany.
⁴ Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, Ulm University Hospital, Ulm, Germany.

No abstract available

Publication types

Letter

MeSH terms

Autoimmune Pancreatitis*
COVID-19 Vaccines* / administration & dosage
COVID-19* / prevention & control
Humans
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines